Mike Pompeo switches his critical role from CIA Director to State Secretary in a secret visit to North Korea.
Peter Prince

2018-04-13 14:42:00 Fri ET

Mike Pompeo switches his critical role from CIA Director to State Secretary in a secret visit to North Korea with no regime change as the North Korean dictator Kim Jong-Un intends to end the 65-year Korean War. Major U.S. and East Asian stock markets experience healthy gains in response to this positive result.

Pompeo is now the most senior U.S. diplomat who directly meets and approaches Kim. This secret visit signals the fact that President Trump sends goodwill to the North Korean leader prior to their bilateral peace summit. The recent core dialogue between Kim and Pompeo upholds the genuine belief that Trump can engage in productive negotiations with North Korea over its intercontinental ballistic missile programs. Trump-Kim direct talks help strengthen the plausible case for peace and denuclearization on the Korean peninsula in the next decade.

Pompeo remains optimistic about a Trump-Kim peace summit during his Senate confirmation testimony for his fresh post of State Secretary. At this stage, Pompeo expects the peace summit to happen for a positive diplomatic outcome with North Korea. This summit serves as an incremental step toward Korean denuclearization, and the current dialogue helps alleviate the current nuclear threat from North Korea. The Trump team plans to continue the current U.N.-driven economic sanctions on North Korea until its complete and comprehensive denuclearization.

 


If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.

Blog+More
The social media factor serves as a new measure of investor sentiment in addition to the fundamental factors.
Rose Prince

2017-05-07 06:39:00 Sunday ET

The social media factor serves as a new measure of investor sentiment in addition to the fundamental factors.

While the original five-factor asset pricing model arises from a quasi-lifetime of top empirical research by Nobel Laureate Eugene Fama and his long-time co

+See More
Facebook, Twitter, and Google executives explain the scope of Russian interference in the U.S. 2016 presidential election.
Apple Boston

2017-09-19 05:34:00 Tuesday ET

Facebook, Twitter, and Google executives explain the scope of Russian interference in the U.S. 2016 presidential election.

Facebook, Twitter, and Google executives head before the Senate Judiciary Committee to explain the scope of Russian interference in the U.S. presidential el

+See More
China, Russia, France, Germany, and Japan may dethrone the petrodollar.
Jacob Miramar

2018-07-01 08:34:00 Sunday ET

China, Russia, France, Germany, and Japan may dethrone the petrodollar.

Are China and Russia etc gonna dethrone the petrodollar? Over the years, China, Russia, France, Germany, and Japan have made numerous attempts to use their

+See More
Leon Cooperman points out that the current Trump stock market rally now approaches normalization.
Amy Hamilton

2017-10-27 06:35:00 Friday ET

Leon Cooperman points out that the current Trump stock market rally now approaches normalization.

Leon Cooperman, Chairman and CEO of Omega Advisors, points out that the current Trump stock market rally now approaches normalization. The U.S. stock market

+See More
President Trump criticizes the WTO and proposes indexing capital gains taxes to inflation for U.S. investors.
Charlene Vos

2018-08-29 10:37:00 Wednesday ET

President Trump criticizes the WTO and proposes indexing capital gains taxes to inflation for U.S. investors.

In an exclusive interview with Bloomberg, President Trump criticizes the World Trade Organization (WTO), proposes indexing capital gains taxes to inflation

+See More
The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.
Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More